Mariana Moreno de Sousa Rodrigues

5PUBLICATIONS
11CO-AUTHORS
Molecular targetsMedical bacteriologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 15, 2025
Synergistic Reduction of Breast Cancer Cell Viability and Aggressiveness Through Dual Inhibition of APE1 Redox Function and STAT3 Signaling.

Mariana Moreno de Sousa Rodrigues, Priscyanne Barreto Siqueira, Ana Clara Cavallo Dobao

|Oct 13, 2024
APX2009 sensitizes hypoxic breast cancer cells to doxorubicin by increasing its accumulation and caspase-3/7-mediated apoptosis.

Ísis Salviano Soares de Amorim, Daphne Pinheiro, Matheus da Silva Oliveira

|May 29, 2024
The inhibitor of the redox activity of APE1/REF-1, APX2009, reduces the malignant phenotype of breast cancer cells.

P B Siqueira, M M S Rodrigues, Ĺ S S de Amorim

|May 22, 2024
Does photobiomodulation alter mitochondrial dynamics?

Larissa Alexsandra da Silva Neto Trajano, Priscyanne Barreto Siqueira, Mariana Moreno de Sousa Rodrigues

|Jan 02, 2024
The APE1/REF-1 and the hallmarks of cancer.

Priscyanne Barreto Siqueira, Mariana Moreno de Sousa Rodrigues, Ísis Salviano Soares de Amorim

Pageof 1

Frequent Collaborators

4 joint publications

Priscyanne Barreto Siqueira

4 joint publications

Adenilson de Souza da Fonseca

4 joint publications

Andre Luiz Mencalha

3 joint publications

Ĺ S S de Amorim